Artificial Intelligence-Assisted Comparative Analysis of the Overlapping Molecular Pathophysiology of Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia
- PMID: 39769215
- PMCID: PMC11678588
- DOI: 10.3390/ijms252413450
Artificial Intelligence-Assisted Comparative Analysis of the Overlapping Molecular Pathophysiology of Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia
Abstract
The overlapping molecular pathophysiology of Alzheimer's Disease (AD), Amyotrophic Lateral Sclerosis (ALS), and Frontotemporal Dementia (FTD) was analyzed using relationships from a knowledge graph of 33+ million biomedical journal articles. The unsupervised learning rank aggregation algorithm from SemNet 2.0 compared the most important amino acid, peptide, and protein (AAPP) nodes connected to AD, ALS, or FTD. FTD shared 99.9% of its nodes with ALS and AD; AD shared 64.2% of its nodes with FTD and ALS; and ALS shared 68.3% of its nodes with AD and FTD. The results were validated and mapped to functional biological processes using supervised human supervision and an external large language model. The overall percentages of mapped intersecting biological processes were as follows: inflammation and immune response, 19%; synapse and neurotransmission, 19%; cell cycle, 15%; protein aggregation, 12%; membrane regulation, 11%; stress response and regulation, 9%; and gene regulation, 4%. Once normalized for node count, biological mappings for cell cycle regulation and stress response were more prominent in the intersection of AD and FTD. Protein aggregation, gene regulation, and energetics were more prominent in the intersection of ALS and FTD. Synapse and neurotransmission, membrane regulation, and inflammation and immune response were greater at the intersection of AD and ALS. Given the extensive molecular pathophysiology overlap, small differences in regulation, genetic, or environmental factors likely shape the underlying expressed disease phenotype. The results help prioritize testable hypotheses for future clinical or experimental research.
Keywords: Alzheimer’s disease (AD); amyotrophic lateral sclerosis (ALS); frontotemporal dementia (FTD); knowledge graph; literature-based discovery; machine learning; network regulation; neuropathology; neurophysiology; pathology dynamics.
Conflict of interest statement
The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures







Similar articles
-
Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.Neurobiol Dis. 2021 Jul;154:105360. doi: 10.1016/j.nbd.2021.105360. Epub 2021 Mar 31. Neurobiol Dis. 2021. PMID: 33812000 Free PMC article. Review.
-
TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.Neurobiol Dis. 2020 Dec;146:105130. doi: 10.1016/j.nbd.2020.105130. Epub 2020 Oct 14. Neurobiol Dis. 2020. PMID: 33065281 Free PMC article.
-
Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.JAMA Neurol. 2018 Jul 1;75(7):860-875. doi: 10.1001/jamaneurol.2018.0372. JAMA Neurol. 2018. PMID: 29630712 Free PMC article.
-
Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.Trends Mol Med. 2016 Sep;22(9):769-783. doi: 10.1016/j.molmed.2016.07.005. Epub 2016 Aug 4. Trends Mol Med. 2016. PMID: 27498188 Review.
-
A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.EMBO Mol Med. 2018 Jan;10(1):48-62. doi: 10.15252/emmm.201708202. EMBO Mol Med. 2018. PMID: 29191947 Free PMC article.
Cited by
-
Genetic structure of different ethnic populations at the frontotemporal dementia risk loci.PLoS One. 2025 Aug 5;20(8):e0329809. doi: 10.1371/journal.pone.0329809. eCollection 2025. PLoS One. 2025. PMID: 40763168 Free PMC article.
References
-
- Strong M.J., Abrahams S., Goldstein L.H., Woolley S., Mclaughlin P., Snowden J., Mioshi E., Roberts-South A., Benatar M., HortobáGyi T., et al. Amyotrophic lateral sclerosis-frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph. Lateral Scler. Frontotemporal Degener. 2017;18:153–174. doi: 10.1080/21678421.2016.1267768. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous